Cubitan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cubitan

Quick Facts

Property Description
Active Ingredient L-Arginine, Cow's Milk Protein, Vitamin C, Zinc
Form Ready-to-drink Liquid Nutritional Supplement (Milkshake Style)
Pharmacological Class Food for Special Medical Purposes (FSMP)
General Use Dietary management of chronic wounds (e.g., pressure ulcers)
Manufacturer Nutricia

What Classification of Nutritional Supplement is Cubitan?

Cubitan is classified as a Food for Special Medical Purposes (FSMP) and a specialized enteral nutrition preparation intended for the dietary management of chronic wounds. It is categorized as a high protein and high energy (hypercaloric) oral nutritional supplement. This specific classification ensures its composition is tailored to address the significantly increased nutritional requirements of individuals whose dietary intake is insufficient for proper healing. Due to its specialized nature, the product requires professional medical supervision for its use. This type of nutritional formula is used to manage conditions that impair the body's natural healing capacity.


What is Cubitan Made Of, and What is its Unique Form?

Distributed by Nutricia, the product is supplied as a ready-to-drink liquid nutritional supplement in a 200ml bottle, designed in a milkshake style to aid patient compliance. The formula's primary components include Cow's Milk Protein, essential for tissue structure, combined with energy sources such as maltodextrin, sucrose, and a blend of vegetable oils. A notable compositional characteristic is its specific fortification with the amino acid L-Arginine, alongside key micronutrients like Vitamin C, Zinc, Selenium, and Vitamin E. The formula is gluten-free and low lactose, making it suitable for patients with these specific dietary sensitivities.


What is the General Purpose of Cubitan?

Cubitan's general purpose is to provide targeted nutritional support to facilitate the body's natural processes of tissue repair and regeneration when compromised. The product is specifically indicated for the dietary management of chronic wounds, including pressure ulcers (bedsores) and leg ulcers. This function is focused on the L-Arginine content, which plays a role in protein synthesis and the healing process, particularly by supporting collagen synthesis. The supplement provides the amino acid substrates required for the body to build and repair damaged tissue.

What side effects are possible with Cubitan?

Possible side effects and safety information

Cubitan is classified as a Food for Special Medical Purposes (FSMP), and its safety profile is determined by regulatory constraints, contraindications, and potential adverse effects related to its specific, high-concentration components.


System-Organ Classifications and Expected Effects

The most commonly noted potential adverse effects involve the Gastrointestinal system, which are associated with the high concentration of the conditionally essential amino acid L-Arginine. These effects can include abdominal discomfort, stomach pain, bloating, nausea, and diarrhea. Additionally, the L-Arginine content has been linked to effects on the Vascular system, with the potential for low blood pressure.

Contraindications and Serious Safety Constraints

The product is subject to explicit contraindications. It is not suitable for use in individuals diagnosed with galactosaemia or those who have experienced a recent myocardial infarction (heart attack). Furthermore, the formula contains cow's milk protein and must not be used by individuals with a known Cow's Milk Protein Allergy.


Safety Considerations in Special Populations

Official documents restrict the use of this specialized supplement in certain patient groups. Cubitan is not suitable for children under three years of age and is not recommended for use in critically ill patients. It should also be used with caution in children and adolescents aged 3 to 17 years.

Safety-Related Limitations

As an FSMP, a fundamental safety constraint is that the product must be used only under medical supervision and is not suitable as a sole source of nutrition.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose (acute excessive intake) of this nutritional formula by focusing on the documented toxicity of its high-concentration components, such as zinc and L-Arginine.

Documented Overdose Presentations

Manifestation Type Officially Documented Symptoms/Signs
Gastrointestinal Nausea, vomiting, diarrhea, abdominal pain
Specific Systemic Metallic taste (associated with acute zinc toxicity), low blood pressure

Acute ingestion may lead to severe gastrointestinal distress, which poses a critical risk for severe dehydration and subsequent acute renal impairment. In case of suspected over-ingestion or the onset of severe, persistent symptoms, the official mandate is to seek medical help right away and contact the Poison Help hotline immediately. Treatment is generally symptomatic and supportive, focusing on managing fluid and electrolyte imbalances. No specific antidote is known for the overall formulation.

Population-specific considerations noted in regulatory guidance indicate that individuals with pre-existing renal impairment are at an increased risk of adverse effects from the product's high nutrient load.

Therapeutic Uses of Cubitan

What Cubitan Treats: Main Uses and Benefits

Specialized nutritional support may be part of symptomatic management, especially in contexts involving tissue-related discomfort or strain. Cubitan is applied across domains where additional symptomatic support is needed to help address symptom clusters that may become intense or disruptive during recovery.

Cubitan is generally used across conditions presenting with acute episodes or recurrent manifestations that may lead to symptoms that create noticeable physiological strain. This product contributes to easing the overall symptom load related to physical discomfort and **systemic or localized discomfort.

“This product contributes to easing the overall symptom load related to physical discomfort.”

Specialized Support and Stability

Applied in clinical settings that involve acute or unstable symptom patterns, this supplement contributes to improved comfort during periods of heightened symptoms. It assists with maintaining functional stability and may help patients cope more steadily with symptom fluctuations. It supports general well-being during symptomatic phases by providing supportive nutritional elements that are relevant during recovery and symptomatic phases.


Quick Fact: Support for Physical Discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Cubitan?

As a Food for Special Medical Purposes (FSMP), the eligibility for Cubitan is strictly defined by regulatory documents and requires medical supervision. The profile outlines specific populations that are permitted to use the product and those who must not, based on ingredient compatibility and clinical status.


Eligibility Status and Restrictions

Age Group / Condition
Permitted Use Adults managing chronic wounds or disease-related malnutrition.
Conditional Use Children and adolescents aged 3 to 17 years (use with caution).
Contraindicated Infants and children under 3 years of age.

Absolute Contraindications

Cubitan is officially contraindicated and not suitable for individuals with the following conditions:

  • Galactosaemia
  • Known cow's milk protein allergy

Additionally, the product is not recommended for critically ill patients and must not be used as a sole source of nutrition or administered via the intravenous route. This information is based solely on official, label-documented restrictions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Cubitan is determined by the high-dose nutritional components it contains, including L-Arginine, Zinc, and high protein.

Category Officially Documented Interaction Pattern
Cardiovascular/Electrolytes L-Arginine may cause an additive hypotensive effect when co-administered with Vasodilators (e.g., Nitrates). Co-administration with Potassium-Sparing Diuretics may increase the risk of hyperkalemia (elevated potassium levels).
Absorption Interference The Zinc component can form insoluble complexes (chelation) with Tetracycline and Quinolone Antibiotics, which significantly reduces the exposure of the antibiotic.
Nutrient Competition The high protein content may interfere with the absorption and transport of Levodopa, which is officially described as potentially reducing the medicine's systemic availability.
Mineral Uptake The Vitamin C component is documented to increase the absorption and bioavailability of non-heme iron supplements.

Interaction-Related Constraints and Requirements

Regulatory guidance establishes specific time-separation requirements for administration: the supplement must be administered at least 2 to 6 hours apart from certain Tetracycline and Quinolone Antibiotics to prevent compromised antibiotic efficacy. Cautions concerning L-Arginine-related interactions are stated to be of heightened relevance in populations with renal or hepatic impairment. The regulatory structure mandates awareness of these specific pharmacodynamic and chelation-based constraints.

Mechanism of Action

How Cubitan Works

The mechanism of Cubitan is based on the coordinated supply of specific nutritional cofactors and metabolic precursors (L-Arginine, Cow's Milk Protein, Vitamin C, and Zinc) that directly engage and modulate pathways that support tissue organization. This focused approach provides the specific molecular inputs required for the sustained tissue organization cascade.


Driving Substrate Availability and Protein Synthesis

This domain focuses on providing a critical supply of amino acid substrates (from Cow's Milk Protein) and the conditionally essential L-Arginine, which serves as a precursor for tissue-building components. This substrate loading drives anabolic pathways, supporting the efficient synthesis of new structural proteins, which contributes to tissue organization.


Strengthening the Collagen Structure via Cofactor Activation

This mechanism centers on Vitamin C's role as an obligatory cofactor for Prolyl and Lysyl Hydroxylases. The activation of these enzymes drives the chemical stabilization of the newly formed collagen chains through proper cross-linking. This process contributes to the tensile strength and structural integrity of the newly organized matrix.


Modulating Vascular Dynamics and Cell Proliferation

This mechanism involves the dual actions of L-Arginine (as a substrate for Nitric Oxide production) and Zinc (as a key enzymatic cofactor). The local generation of NO supports vasodilation and angiogenesis, which modulates local blood flow and supports oxygen delivery, while Zinc accelerates the mitosis of fibroblasts and keratinocytes, thereby supporting the cellular movements and epithelial migration involved in the tissue defect closure cascade.

Dosage and Administration Information

How to Use Cubitan: Official Administration Guidelines

Cubitan is classified as a Food for Special Medical Purposes (FSMP) and must be administered strictly under medical supervision. Its use is governed by official instructions establishing the specific intake method, frequency, and volume, as required for a supplemental nutritional intervention.


Administration Scope

Category Instruction Detail
Route of Administration For oral consumption or delivery via an enteral feeding tube only; it is not suitable for intravenous use.
Dosing Schedule The typical daily intake ranges from 1 to 3 bottles (200 ml) per day, with the precise dosage determined by a doctor or dietitian based on clinical need.
Timing Should be consumed in between meals or at snack times, as it is intended to supplement, and not replace, the regular diet.
Preparation The product is ready to drink and must be shaken well before opening. It is generally best served chilled.
Population Restrictions The product is not suitable for children under 3 years of age, and its use in adolescents aged 3 to 17 years requires careful caution and medical guidance.

Procedural Structure and Handling

This supplement is designed to be used as part of a daily regimen. After opening, any liquid that is not consumed immediately must be refrigerated for a maximum of 24 hours, after which the unused contents must be discarded. The instruction to use Cubitan only as a supplement and never as a sole source of nutrition is a core contextual constraint of its official use.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical research has focused on the use of this specific oral nutritional supplement (ONS) in the dietary management of pressure ulcers (PUs), also known as bedsores. The supplement is rich in protein and energy, and fortified with the amino acid arginine, the mineral zinc, and antioxidant vitamins (A, C, and E).


Efficacy in Pressure Ulcer Healing

Several randomized controlled trials (RCTs) and systematic reviews have explored the effects of the enriched ONS in patients, often comparing it to standard nutritional formulas or a placebo. Key findings observed in these studies include:

  • Reduction in Ulcer Area: Studies in malnourished and non-malnourished patients with Stage II–IV pressure ulcers have shown a statistically significant greater reduction in the pressure ulcer area compared to control groups, typically over an 8-week intervention period.
  • Healing Rate: In some studies, supplementation with the enriched ONS was associated with a faster rate of healing, as measured by standardized tools like the Pressure Ulcer Scale for Healing (PUSH) score, with differences sometimes observed as early as four weeks.

Comparative and Supportive Data

Research has also investigated secondary effects related to wound care and the underlying nutritional status:

  • Wound Care Intensity: Some trial results indicated that the use of the enriched ONS led to a reduced number of dressings required per week, suggesting a decrease in the intensity of local wound care activities.
  • Nutritional Status: In addition to wound measures, studies have documented improvements in nutritional markers, such as increases in serum albumin levels and handgrip strength in specific patient populations, supporting the role of comprehensive nutritional support.

Frequently Asked Questions (FAQ)

Common questions about Cubitan (FAQ)

Q: How quickly can one generally expect to see any effect from Cubitan?

Clinical studies investigating the efficacy of this specialized nutritional support have sometimes noted statistically significant differences in healing rates compared to control groups as early as four weeks. Clinical assessments often track the effects of the nutritional support over a defined period, such as an eight-week intervention. Individual response is dependent on the patient's overall nutritional status and health condition.

Q: Does Cubitan cause drowsiness or affect ability to drive?

The official safety information for Cubitan does not list drowsiness or any direct impact on the ability to drive or operate machinery as a known adverse effect. However, the documentation does note the potential for low blood pressure as a vascular effect associated with one of its specific components. Any concerns regarding potential effects should be addressed by the supervising healthcare professional.

Q: Are there any common food or drink interactions with Cubitan?

The official administration guidelines for this specialized nutritional supplement specify that it is intended to be consumed in between meals or as a snack to supplement the regular diet, not replace it. Beyond this timing constraint, general food or drink restrictions are not typically detailed in the product's regulatory documentation. Known interactions are primarily with certain medicines, as detailed in the relevant section.

Q: What does official research say about the benefits of Cubitan?

Official research and evidence themes specifically support the use of Cubitan in the dietary management of chronic wounds, such as pressure ulcers (bedsores) and leg ulcers. The clinical studies focus on measuring outcomes like the reduction in ulcer area and an improved rate of healing over the course of the nutritional support regimen.

Q: Is it normal to feel a slight stomach discomfort when starting Cubitan?

The product's safety information lists Gastrointestinal (GI) effects, including abdominal discomfort, stomach pain, bloating, nausea, and diarrhea, as potential adverse effects. These are associated with the high concentration of the specific nutritional components, particularly the amino acids. The occurrence of these GI effects is considered a possibility.

Q: Can Cubitan affect blood pressure or heart rate?

The official safety documentation confirms that the supplement's L-Arginine content has been linked to effects on the Vascular system, specifically noting the potential for low blood pressure. There are no documented direct effects on the heart rate within the official safety constraints.

Q: Can older adults safely use Cubitan?

Official documentation indicates use is permitted for adults who are managing chronic wounds or disease-related malnutrition. While there are specific contraindications for children and critically ill patients, there are no additional restrictions specifically for older adults. The product is always required to be used under medical supervision to determine individual suitability.

Q: Are there any specific warnings about using Cubitan during pregnancy?

Official regulatory documents typically outline use during pregnancy and lactation for specialized products. The specific warnings and contraindications listed in the safety information do not explicitly include pregnancy or breastfeeding, which means a healthcare professional must evaluate the use of this nutritional product during these periods.

Q: Does Cubitan interact with common pain relievers like ibuprofen or acetaminophen?

The official interaction profile details constraints with specific drug classes, such as Vasodilators, certain Antibiotics, and Levodopa. Interactions with commonly available over-the-counter pain relievers, like ibuprofen or acetaminophen, are not explicitly described in the regulatory documentation. Co-administration with other products should be discussed with the supervising healthcare professional.

Q: Is there a maximum period Cubitan is typically recommended for?

Cubitan is indicated for the dietary management of chronic wounds, which requires ongoing support. Clinical studies often assess efficacy over an eight-week intervention period. However, the precise duration of use is not fixed and is determined by the supervising doctor or dietitian based on the patient's individual clinical needs and progress.

Q: What if I have an underlying health condition; can I still use Cubitan?

The product has specific safety constraints and is contraindicated for certain conditions, including galactosaemia, cow's milk protein allergy, and recent myocardial infarction. Due to its classification, it must be used under medical supervision so that a healthcare professional can assess its suitability in light of all underlying health conditions.

Q: Is Cubitan safe to use alongside multivitamins?

The official interaction profile notes that the Vitamin C component within Cubitan is documented to increase the absorption and bioavailability of non-heme iron supplements. While the use of other micronutrient supplements (like multivitamins) is not generally restricted, the supervising professional should be aware of all concurrent nutritional products being used.

Q: What is the main difference between Cubitan and other similar support products?

Cubitan is officially classified as a specialized high protein, high energy oral nutritional supplement. Its unique characteristic is its specific and high-level fortification with the conditionally essential amino acid L-Arginine, alongside key nutrients like Vitamin C and Zinc. This unique composition is tailored for the dietary management of chronic wounds.

Q: Why do some people online say Cubitan did not work for them?

Official guidelines emphasize that this specialized supplement must be used under medical supervision as part of a comprehensive nutritional care plan. While clinical evidence shows positive results in patient groups, individual response can vary, and outcomes are influenced by the patient's nutritional status and adherence to the prescribed medical management plan.

Q: Is there a generic version of Cubitan available?

Cubitan is a proprietary product, classified as a Food for Special Medical Purposes (FSMP) and is manufactured by Nutricia. It is a specific, specialized nutritional formulation enriched with L-Arginine. Due to its unique and defined composition, an identical, non-branded generic equivalent of this product is not available.

Q: Why do doctors often recommend Cubitan?

Official documents describe the product as indicated for the dietary management of chronic wounds due to its specific composition. Its high-protein, high-energy nutritional support, enriched with L-Arginine, is consistent with clinical guidelines for supporting the tissue repair process.

Q: Can Cubitan be used temporarily or does it need long-term use?

Cubitan is intended to provide nutritional support for conditions requiring tissue repair, which can be an ongoing process. While clinical studies have defined trial periods, the actual length of use is determined by the supervising healthcare professional based on the individual patient's medical condition and the progression of their recovery.

Q: Is it true that Cubitan causes headaches for some people?

Official safety information lists common potential adverse effects related to the Gastrointestinal and Vascular systems, such as abdominal discomfort and low blood pressure. Headaches are not explicitly listed among the potential adverse effects in the safety constraints documented for this product.

Q: Is Cubitan covered by insurance?

As a Food for Special Medical Purposes (FSMP), the coverage or reimbursement status of Cubitan is typically determined by local and national insurance providers and health schemes. Policies often have specific criteria for the coverage of specialized nutritional products, and this must be verified on a case-by-case basis.

Q: What is the source of the ingredient in Cubitan?

The official product composition lists Cow's Milk Protein as a major structural component. The formula is also certified as gluten-free and low lactose. It also includes various energy sources like vegetable oils and carbohydrates.

Q: What does the packaging label mean when it describes Cubitan's purpose?

The label describes Cubitan as a Food for Special Medical Purposes (FSMP) for the dietary management of chronic wounds. This is a regulatory classification confirming that the product is a specialized nutritional formula intended to be used only under medical supervision to address the unique, significantly increased nutritional requirements of the patient.

Q: Is the evidence for Cubitan based on large human studies?

The evidence themes supporting the product's function are officially derived from findings from Randomized Controlled Trials (RCTs) and systematic reviews. These types of human studies are considered authoritative in the field of nutritional science for supporting the claims related to the dietary management of chronic wounds.

Q: Does Cubitan have different safety warnings in different countries?

The core safety constraints and contraindications for specialized nutritional products like Cubitan are primarily driven by the product's composition. While minor packaging details may differ, the fundamental safety warnings required by national regulatory authorities are typically consistent across major jurisdictions.

Q: What should I do if the side effects of Cubitan seem too strong?

The official guidelines require Cubitan to be used under medical supervision for ongoing monitoring of the patient's condition. If any potential adverse effects, such as abdominal discomfort or low blood pressure, become difficult to manage, communication with the supervising healthcare professional is advised due to the requirement for medical supervision.

Q: Can Cubitan cause weight changes?

Cubitan is officially classified as a high energy (hypercaloric) nutritional supplement, providing a high calorie count along with high protein. This composition is specifically intended to help patients meet their significantly increased nutritional needs, and it can support the maintenance or increase of body weight in individuals who are malnourished.

Q: Is it possible to become dependent on Cubitan?

Cubitan is classified as a specialized nutritional supplement for the dietary management of specific medical conditions, and not a psychoactive drug. It is used to provide temporary nutritional support until the clinical need for the specific formulation is resolved, and its use is always governed by professional medical direction.

Q: What is the evidence quality for Cubitan's claims?

The evidence supporting the product's claims is officially based on findings from high-quality study designs, including Randomized Controlled Trials (RCTs) and systematic reviews. This level of evidence is used to demonstrate the supplement's efficacy in the dietary management of chronic wounds.

Q: Is Cubitan often used in hospitals or clinical settings?

The product is classified as a Food for Special Medical Purposes (FSMP) and its use is strictly required to be under medical supervision. This classification indicates that the product is intended for the specific and highly specialized nutritional management of patients, often in a professionally guided clinical setting where monitoring is available.

How should Cubitan be stored and disposed of?

Storage and Disposal of Cubitan

Cubitan, a Food for Special Medical Purposes (FSMP), must be stored according to specific product label instructions to maintain stability.

Unopened Storage

The unopened bottle must be stored in a cool, dry place at temperatures between 5 C and 25 C. The product is valid until the Best Before date printed on the packaging.

Stability After Opening

Once opened, the bottle must be closed and stored immediately in a refrigerator. If refrigerated, the contents must be consumed within 24 hours. If stored at room temperature, consumption must occur within 4 hours.

Handling and Disposal

Before use, the bottle should be shaken well. Cubitan is for enteral use only. Any unused contents that exceed the post-opening time limits must be discarded according to local regulatory guidelines. The product is not suitable for children under 3 years of age and requires use under medical supervision.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cubitan found in:

A-Z Index: